Suppr超能文献

肝移植受者T管拔除后胆漏的内镜处理:鼻胆管引流与胆管支架置入术对比

Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients: nasobiliary drainage versus biliary stenting.

作者信息

Saab S, Martin P, Soliman G Y, Machicado G A, Roth B E, Kunder G, Han S H, Farmer D G, Ghobrial R M, Busuttil R W, Bedford R A

机构信息

Division of Digestive Diseases and Dumont-University of California at Los Angeles Transplant Program, Los Angeles, CA 90095, USA.

出版信息

Liver Transpl. 2000 Sep;6(5):627-32. doi: 10.1053/jlts.2000.8200.

Abstract

This study presents the long-term sequelae of endoscopic retrograde cholangiopancreatography (ERCP)-managed biliary leakage in patients who underwent orthotopic liver transplantation (OLT) and compares the relative efficacy, safety, and charges of nasobiliary drainage (NBD) versus biliary stenting (BS). We identified all orthotopic liver transplant recipients from January 1, 1993, to December 31, 1997, who had undergone ERCP for biliary leakage. Clinical outcome and charges were calculated on an intention-to-treat basis according to initial endoscopic therapy. Of the 1,166 adult OLTs performed during the study period, 442 patients underwent elective T-tube removal. ERCP was attempted in 69 patients (16%) who developed biliary leakage after T-tube removal. Three patients (5%) in whom initial ERCP was unsuccessful underwent surgery. NBD and BS were used as primary therapy in 45 (68%) and 21 patients (32%), respectively. Three patients initially treated with NBD required reendoscopy or surgery compared with 6 patients initially treated with BS (P <.05). Although not statistically significant, there was a trend toward greater expense in the BS group compared with the NBD group. ERCP is a safe and effective method of managing biliary leakage after T-tube removal in orthotopic liver transplant recipients. However, our results suggest NBD is the preferred method because recurrent leaks were more common in patients treated initially with BS. With prompt use of ERCP, surgery is rarely needed for this complication of OLT.

摘要

本研究呈现了接受原位肝移植(OLT)患者经内镜逆行胰胆管造影(ERCP)处理胆漏的长期后遗症,并比较了鼻胆管引流(NBD)与胆管支架置入(BS)的相对疗效、安全性及费用。我们确定了1993年1月1日至1997年12月31日期间所有因胆漏接受ERCP的原位肝移植受者。根据初始内镜治疗,按意向性治疗原则计算临床结局和费用。在研究期间进行的1166例成人OLT中,442例患者接受了选择性T管拔除。69例(16%)T管拔除后发生胆漏的患者尝试了ERCP。3例(5%)初始ERCP未成功的患者接受了手术。NBD和BS分别作为45例(68%)和21例(32%)患者的主要治疗方法。初始接受NBD治疗的3例患者需要再次内镜检查或手术,而初始接受BS治疗的有6例患者(P<.05)。尽管无统计学意义,但与NBD组相比,BS组有费用更高的趋势。ERCP是原位肝移植受者T管拔除后处理胆漏的一种安全有效的方法。然而,我们的结果表明NBD是首选方法,因为初始接受BS治疗的患者复发性胆漏更常见。通过及时使用ERCP,OLT的这种并发症很少需要手术治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验